These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1606083)

  • 1. Stage I malignant lymphoma of Waldeyer's ring: frequent relapse after radiation therapy.
    Takagi T; Sampi K; Iida K
    Ann Oncol; 1992 Feb; 3(2):137-9. PubMed ID: 1606083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of non-Hodgkin's lymphoma of Waldeyer's ring: radiotherapy versus chemotherapy versus combined therapy.
    Avilés A; Delgado S; Ruiz H; de la Torre A; Guzman R; Talavera A
    Eur J Cancer B Oral Oncol; 1996 Jan; 32B(1):19-23. PubMed ID: 8729614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Non-Hodgkin's lymphoma of the Waldeyer's ring: the treatment results of the past 22 years and the significance of CHOP].
    Hiramatsu H; Kondo M; Uematsu M; Shigematsu N; Ando Y; Hashimoto S
    Nihon Gan Chiryo Gakkai Shi; 1990 Oct; 25(10):2477-83. PubMed ID: 2262731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stage IA non-Hodgkin's lymphoma of the Waldeyer's ring. Limited chemotherapy and radiation therapy versus radiation therapy alone.
    Uematsu M; Kondo M; Hiramatsu H; Ikeda Y; Mikata S; Katayama M; Ito H; Kusano S; Kubo A
    Acta Oncol; 1993; 32(6):675-8. PubMed ID: 8260187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe chemotherapy-induced recall of radiation mucositis in a patient with non-Hodgkin's lymphoma of Waldeyer's ring.
    Eifel PJ; McClure S
    Int J Radiat Oncol Biol Phys; 1989 Oct; 17(4):907-8. PubMed ID: 2476427
    [No Abstract]   [Full Text] [Related]  

  • 6. [Radiotherapy and chemotherapy in stages I and II non-Hodgkin's lymphomas of Waldeyer's ring].
    Hayabuchi N; Jingu K; Miyoshi M; Akasi Y; Masuda K; Komiyama S; Kikuchi M
    Nihon Gan Chiryo Gakkai Shi; 1990 Jul; 25(7):1428-36. PubMed ID: 2212835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-Hodgkin's lymphoma of Waldeyer's ring.
    Albada J; Hordijk GJ; van Unnik JA; Dekker AW
    Cancer; 1985 Dec; 56(12):2911-3. PubMed ID: 3840405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors and therapeutic efficacy of combined radio-chemotherapy in Waldeyer's ring non-Hodgkin lymphoma.
    Yong W; Zhang Y; Zheng W; Wei Y
    Chin Med J (Engl); 2000 Feb; 113(2):148-50. PubMed ID: 11775540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Initial anthracycline-based chemotherapy without radiotherapy in patients older than 70 years with localized lymphoma arising from Waldeyer's ring].
    Sampi K; Takagi T; Morii K; Hattori M
    Gan To Kagaku Ryoho; 1993 Dec; 20(15):2345-9. PubMed ID: 8259849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilot study of modified version of CHOP plus radiotherapy for early-stage aggressive non-Hodgkin's lymphoma of the head and neck.
    Nishioka T; Tsuchiya K; Nishioka S; Kitahara T; Ohmori K; Homma A; Aoyma H; Shindoh M; Shirato H
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):847-52. PubMed ID: 15465202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy after radiation therapy in stage I low-grade and intermediate-grade non-Hodgkin lymphoma. Results of a prospective randomized study.
    Yahalom J; Varsos G; Fuks Z; Myers J; Clarkson BD; Straus DJ
    Cancer; 1993 Apr; 71(7):2342-50. PubMed ID: 8453557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors and treatment outcome in non-Hodgkin's lymphoma of Waldeyer's ring.
    Harabuchi Y; Tsubota H; Ohguro S; Himi T; Asakura K; Kataura A; Ohuchi A; Hareyama M
    Acta Oncol; 1997; 36(4):413-20. PubMed ID: 9247103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of radiation therapy of stage II non-Hodgkin's lymphoma of the Waldeyer's ring: a report of the Japanese Lymphoma Radiation Therapy Study Group].
    Masaki N; Ikeda H; Kaneta K; Morita K; Niibe H; Watanabe S; Hayabuchi N; Horiuchi J
    Gan No Rinsho; 1988 Apr; 34(5):612-8. PubMed ID: 3385927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes for stage I-II aggressive non-Hodgkin lymphoma of Waldeyer's ring.
    Chang DT; Mendenhall NP; Lynch JW; Morris CG; Olivier KR
    Am J Clin Oncol; 2009 Jun; 32(3):233-7. PubMed ID: 19433961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermediate-grade lymphomas treated with cyclophosphamide-doxorubicin- vincristine-prednisone-bleomycin alternated with cyclophosphamide-methotrexate-etoposide-dexamethasone. Application of prognostic models to data analysis.
    Velasquez WS; McLaughlin P; Fuller LM; Allen PK; Tucker SL; Swan F; Rodriguez MA; Hagemeister FB; Cabanillas FF
    Cancer; 1994 May; 73(9):2408-16. PubMed ID: 7513251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy and radiotherapy for stage I intermediate or high grade non-Hodgkin's lymphomas: results of a strategy that adapts radiotherapy dose to the response after chemotherapy.
    Krol AD; Berenschot HW; Doekharan D; Henzen-Logmans S; van der Holt B; van 't Veer MB
    Radiother Oncol; 2001 Mar; 58(3):251-5. PubMed ID: 11230885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Limited chemotherapy and radiotherapy for stage I-II intermediate or high grade lymphoma of nodal sites or Waldeyer's ring].
    Uematsu M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1991 Aug; 51(8):962-9. PubMed ID: 1945778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome and patterns of failure in testicular lymphoma: a multicenter Rare Cancer Network study.
    Zouhair A; Weber D; Belkacémi Y; Ketterer N; Dietrich PY; Villà S; Scandolaro L; Bieri S; Studer G; Delacretaz F; Girardet C; Mirimanoff RO; Ozsahin M;
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):652-6. PubMed ID: 11849786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-Hodgkin's lymphoma of the paranasal sinuses: clinical and pathological features, and response to combined-modality therapy.
    Hausdorff J; Davis E; Long G; Hoppe R; van der Pas M; Lassman C; Kamel O; Jacobs C
    Cancer J Sci Am; 1997; 3(5):303-11. PubMed ID: 9327155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors of stage I and II non-Hodgkin's lymphomas of the head and neck: the value of the working formulation and need for chemotherapy.
    Shigematsu N; Kondo M; Mikata A
    Int J Radiat Oncol Biol Phys; 1988 Nov; 15(5):1111-8. PubMed ID: 3182343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.